Compare RAPP & TTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | RAPP | TTI |
|---|---|---|
| Founded | 2022 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Oil & Gas Production |
| Sector | | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 2024 | 1990 |
| Metric | RAPP | TTI |
|---|---|---|
| Price | $26.92 | $11.71 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $47.80 | $10.25 |
| AVG Volume (30 Days) | 427.2K | ★ 2.1M |
| Earning Date | 11-06-2025 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 7085.43 |
| EPS | N/A | ★ 0.92 |
| Revenue | N/A | ★ $618,755,000.00 |
| Revenue This Year | N/A | $5.52 |
| Revenue Next Year | N/A | $4.44 |
| P/E Ratio | ★ N/A | $12.68 |
| Revenue Growth | N/A | ★ 0.17 |
| 52 Week Low | $6.43 | $2.03 |
| 52 Week High | $42.27 | $11.71 |
| Indicator | RAPP | TTI |
|---|---|---|
| Relative Strength Index (RSI) | 42.60 | 80.27 |
| Support Level | $26.30 | $9.47 |
| Resistance Level | $28.10 | $10.24 |
| Average True Range (ATR) | 1.80 | 0.49 |
| MACD | -0.37 | 0.16 |
| Stochastic Oscillator | 20.07 | 89.81 |
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.
Tetra Technologies Inc is a diversified oil and gas services company, focused on completion fluids and associated products and services, water management, frac flowback, production well testing, offshore rig cooling, and compression services. It has two reporting segments namely Completion Fluids & Products, and Water & Flowback Services. The Completion Fluids & Products Division manufactures and markets clear brine fluids, additives, and associated products and services. Majority of revenue is from Completion Fluids & Products. The company derives maximum revenue from United states.